Active Biotech's election committee appointed
(Thomson Reuters ONE) -
PRESS RELEASE
In accordance with a decision made by the Annual General Meeting held on 15
June, 2017, the Election Committee shall comprise the representatives for the
three largest shareholders, as per end of September 2017, and the Chairman of
the Board.
For the 2018 Annual General Meeting, the Election Committee shall propose Board
members and a Chairman of the Board, and fees to Board members and auditors. The
following individuals were appointed representatives for the largest
shareholders and, accordingly, are members of the Election Committee:
Johnny Sommarlund, MGA Holding
Tomas Billing, Nordstjernan
Per Colleen, Fjärde AP-fonden
Under the leadership of the Chairman of the Board, Mats Arnhög, the Election
Committee shall prepare proposals to be presented to and decided upon at the
Annual General Meeting on May 17, 2018.
Lund, November 17, 2017
Active Biotech AB (publ)
Helén Tuvesson
President and CEO
Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company
with focus on neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory properties, is
in Phase II development for the treatment of primary progressive multiple
sclerosis and Huntington's disease. ANYARA, an immunological substance, has
completed clinical Phase I-II/III studies in patients with pancreatic, lung or
renal cell cancer. Furthermore, commercial activities are conducted for the
tasquinimod, paquinimod and SILC projects. Please visit www.activebiotech.com
for more information.
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46 19 20 00
This information was submitted for publication, through the agency of the
contact person set out above, at 08.30 a.m. CET on November 17, 2017.
Active Biotech's election committee appointed:
http://hugin.info/1002/R/2150295/825356.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Active Biotech via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 17.11.2017 - 08:30 Uhr
Sprache: Deutsch
News-ID 568821
Anzahl Zeichen: 2658
contact information:
Town:
LUND
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 96 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Active Biotech's election committee appointed"
steht unter der journalistisch-redaktionellen Verantwortung von
Active Biotech (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
